Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aneco is a specialized biotechnology company focused on the research, development, and large-scale manufacturing of high-quality peptides for the cosmetic and pharmaceutical industries. Headquartered in Anhui, China, the company utilizes advanced solid-phase and liquid-phase peptide synthesis technologies to produce a wide range of active ingredients. Their portfolio includes well-known cosmetic peptides such as Acetyl Hexapeptide-8 and Palmitoyl Pentapeptide-4, alongside custom peptide synthesis services for pharmaceutical research. Aneco serves a global market, providing raw materials that adhere to international quality standards for personal care and therapeutic applications. The company is recognized for its expertise in peptide chemistry and its ability to scale production from laboratory to industrial levels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aneco.